Impedance Cardiography to Decrease the Risk of Preeclampsia
Status:
Withdrawn
Trial end date:
2020-02-29
Target enrollment:
Participant gender:
Summary
To determine if the use of impedance cardiography can identify appropriate medications for
use in treating chronic hypertensive patients to decrease the risk of preeclampsia.
Phase:
Early Phase 1
Details
Lead Sponsor:
High Risk Obstetrical Consultants University of Tennessee Medical Center